Your browser doesn't support javascript.
loading
Structural dynamics and functional cooperativity of human NQO1 by ambient temperature serial crystallography and simulations.
Grieco, Alice; Boneta, Sergio; Gavira, José A; Pey, Angel L; Basu, Shibom; Orlans, Julien; Sanctis, Daniele de; Medina, Milagros; Martin-Garcia, Jose Manuel.
Affiliation
  • Grieco A; Department of Crystallography and Structural Biology, Institute of Physical Chemistry Blas Cabrera, Spanish National Research Council (CSIC), Madrid, Spain.
  • Boneta S; Departamento de Bioquímica y Biología Molecular y Celular e Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, Zaragoza, Spain.
  • Gavira JA; Laboratory of Crystallographic Studies, IACT (CSIC-UGR), Armilla, Spain.
  • Pey AL; Departamento de Química Física, Unidad de Excelencia en Química Aplicada a Biomedicina y Medioambiente e Instituto de Biotecnología, Universidad de Granada, Granada, Spain.
  • Basu S; European Molecular Biology Laboratory, Grenoble, France.
  • Orlans J; ESRF-The European Synchrotron, Grenoble, France.
  • Sanctis D; ESRF-The European Synchrotron, Grenoble, France.
  • Medina M; Departamento de Bioquímica y Biología Molecular y Celular e Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, Zaragoza, Spain.
  • Martin-Garcia JM; Department of Crystallography and Structural Biology, Institute of Physical Chemistry Blas Cabrera, Spanish National Research Council (CSIC), Madrid, Spain.
Protein Sci ; 33(4): e4957, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38501509
ABSTRACT
The human NQO1 (hNQO1) is a flavin adenine nucleotide (FAD)-dependent oxidoreductase that catalyzes the two-electron reduction of quinones to hydroquinones, being essential for the antioxidant defense system, stabilization of tumor suppressors, and activation of quinone-based chemotherapeutics. Moreover, it is overexpressed in several tumors, which makes it an attractive cancer drug target. To decipher new structural insights into the flavin reductive half-reaction of the catalytic mechanism of hNQO1, we have carried serial crystallography experiments at new ID29 beamline of the ESRF to determine, to the best of our knowledge, the first structure of the hNQO1 in complex with NADH. We have also performed molecular dynamics simulations of free hNQO1 and in complex with NADH. This is the first structural evidence that the hNQO1 functional cooperativity is driven by structural communication between the active sites through long-range propagation of cooperative effects across the hNQO1 structure. Both structural results and MD simulations have supported that the binding of NADH significantly decreases protein dynamics and stabilizes hNQO1 especially at the dimer core and interface. Altogether, these results pave the way for future time-resolved studies, both at x-ray free-electron lasers and synchrotrons, of the dynamics of hNQO1 upon binding to NADH as well as during the FAD cofactor reductive half-reaction. This knowledge will allow us to reveal unprecedented structural information of the relevance of the dynamics during the catalytic function of hNQO1.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Protein Sci Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Protein Sci Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United States